Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: Role in altered high density lipoproteins

Atherosclerosis

Volumn 153, Issue 2, 2000, Pages 491-498

  Beentjes, John A M ^a   Van Tol, Arie ^b   Sluiter, Wim J ^a   Dullaart, Robin P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Acromegaly; Cholesteryl ester transfer protein; Cholesteryl esterification, cholesteryl ester transfer; Growth hormone deficiency; High density lipoproteins; Lecithin:cholesterol acyl transferase; Phospholipid transfer protein

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN;

ACROMEGALY; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN BINDING;

ACROMEGALY; ADULT; CARRIER PROTEINS; GROWTH HORMONE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0034496808     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00433-0     Document Type: Article

References (61)

1. Premature mortality due to cardiovascular disease in hypopituitarism
2. The effect of hypopituitarism on life expectancy
3. Increased cerebrovascular mortality in patients with hypopituitarism
4. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
5. An audit of outcome of treatment in acromegaly
6. Determinants of clinical outcome and survival in acromegaly
7. Mortality and cancer incidence in acromegaly: A retrospective cohort study
8. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
9. The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients
10. LDL subfractions in acromegaly: Relation to growth hormone and insulin-like growth factor-I
11. Serum lipids in acromegaly
12. Lipoprotein (a) in acromegaly
13. Elevation of high density lipoproteins in acromegalics after lisuride treatment
14. High density lipoprotein metabolism
15. Cholesterylester transfer between lipoproteins
16. Plasma cholesteryl ester transfer protein
17. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis
18. Structure and function of the plasma phospholipid transfer protein
19. Human plasma phospholipid transfer protein causes high density lipoprotein conversion
20. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein
21. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: Evidence for particle fusion
22. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL
23. Molecular physiology of reverse cholesterol transport
24. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia
25. Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus
26. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: A review
27. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism
28. Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: Comparison with nonfunctioning macroadenomas
29. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein
30. The determination of total cholesterol in serum by gas-liquid chromatography compared with two other methods
31. Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism
32. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma
33. Lecithin: Cholesterol acyltransferase in liver disease
34. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol
35. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma
36. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer
37. Insulin decreases plasma cholesterylester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes
38. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus
39. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
40. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different
41. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy
42. Plasma phospholipid transfer protein activity is related to insulin resistance: Impaired acute lowering by insulin in obese type II diabetic patients
43. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein
44. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
45. Elevated plasma cholesteryl ester transfer in NIDDM: Relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein
46. Enzymes involved in lipid and lipoprotein metabolism
47. Role of elevated lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients
48. Decline of postheparin plasma lipoprotein lipase in acromegalic patients
49. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes
50. Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement
51. High density lipoproteins and reverse cholesterol transport
52. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis
53. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin:cholesteryl acyltransferase
54. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
55. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
56. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
57. Plasma lipid transfer proteins
58. Cholesteryl ester transfer protein: Friend or foe?
59. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes
60. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: Importance of LpA-I:A-II particles and phospholipid transfer protein
61. Human plasma phospholipid transfer protein is a potential antiatherogenic factor-A study in transgenic mice